CompletedPHASE1, PHASE2NCT02832336

The Effect of Caffeine on the Narcoleptic Patients

Studying Narcolepsy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
King Saud University
Principal Investigator
Mona S Aldosari, Masteral
King Saud University
Intervention
Vivarin(drug)
Enrollment
16 target
Eligibility
18-45 years · All sexes
Timeline
20162018

Study locations (1)

Collaborators

King Saud Medical City

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02832336 on ClinicalTrials.gov

Other trials for Narcolepsy

Additional recruiting or active studies for the same condition.

See all trials for Narcolepsy

← Back to all trials